Authors/Disclosures
|
Dimitrios Arkilo, MD
|
Dr. Arkilo has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Arkilo has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Arkilo has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1. An immediate family member of Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. An immediate family member of Dr. Arkilo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Arkilo has stock in Takeda Pharmaceuticals. Dr. Arkilo has stock in Acadia Pharmaceuticals. Dr. Arkilo has stock in Sage Therapeutics. |
|
Ingo Kleiter
(Neurologische Universitaetsklinik Regensburg)
|
No disclosure on file |
|
Sohail M. Malek, MD
|
No disclosure on file |
|
Sonya G. Wang, MD
(University of Minnesota Department of Pediatrics)
|
Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics. |
|
Tomo Tarui, MD
(Hasbro Children's Hospital, Warren Alpert Medical School of Brown University)
|
Dr. Tarui has nothing to disclose. |